Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Time to turn this puppy around. Green close today!!! Go NYMX!!!!!
could go to $20..stay tuned.
10/11/16 Pr:NYMX Wins Big on Late-Stage Trial.
Go NYMX
Agree because NYMX is a great stock to buy and hold.
Go NYMX
The shorts will go bankrupt if they don't buy NYMX shares TO COVER their BIG short positions.
Go NYMX
Smart traders DON'T use that kind of video chart anymore because it's worthless and because it's obsolete at least six(6) decades ago.
Go NYMX
* * $NYMX Video Chart 10-11-16 * *
Link to Video - click here to watch the technical chart video
getting very close to NDA filing. Expecting a continued price increase and analysts upgrades on the additional new positive news, all IMO
Link:10/11/16 good news.
http://ih.advfn.com/p.php?pid=nmona&article=72639602
$$$$$$$$ Go NYMX
10/11/16 Pr:NYMX Wins Big on Late-Stage Trial.
Go NYMX
NYMX is a Strong BUY.
NYMX has a consensus analyst price target of $10.25
$$$$$Go NYMX
Link: NYMX price target of $10.25
https://finance.yahoo.com/news/nymox-wins-big-stage-trial-160553965.html
Nymox Wins Big on Late-Stage Trial
NYMX is a great stock. Loaded the low $3.00's again recently and love to sell during the $4.00 to $6.00 runs. I agree main shares are still holding for bigger $$$. I play with the rest here.
should get back in the 5's over the next week. pretty amazing results. and tons of trial data. all imo
NYMX awesome news and run to $4.73 today!
getting close now. Very solid support base formed in these low 3's. I think I will add more here and wait for the excitement to start.
File for Approval this quarter or next:
“Nymox has completed and fully financed the execution of seven Phase 3 U.S. BPH (prostate enlargement) clinical protocols, including 2 prospective randomized multicenter single injection double blind clinical trials; 2 U.S. repeat injection clinical trials; and 3 U.S. blinded long-term clinical trial extension studies. In addition, a number of Phase 3 safety and clinical pharmacology studies and analyses have been completed. The Company expects to file for approvals in the next 1-2 quarters. The Company also expects to report further analyses and results when available in the near future. The Company will publish the findings of the fexapotide clinical trials in peer review medical journals as well as in presentations at medical and urological meetings.
“These prospective study results in blinded placebo crossover patients clearly demonstrate that fexapotide reduces the long-term need for surgery by 82-95% compared to approved conventional BPH treatments”, said Dr. Paul Averback MD, CEO of Nymox. “Fexapotide shows significant efficacy against prostate cancer as a therapeutic, and in addition has been shown to reduce the risk of prostate cancer when fexapotide is used to treat BPH. This is in stark contrast to some conventional BPH treatments in routine clinical use today which on the other hand increase prostate cancer risk, and which have many other well known undesirable side effects,” said Dr. Averback.”
http://ih.advfn.com/p.php?pid=nmona&article=72282314
Great Article Today on NYMX:
http://streetregister.com/2016/09/29/nymox-pharmaceutical-corporation-nasdaqnymx-ignore-the-shorts-2/
Waiting for a buy indicator. Should have a nice jump soon
We need more good news on the prostate cancer study. That will drive the stock price to who knows where. This drug could be a life changer for millions of men and put the urologists and their minions out of business. Release the data and show the world this drug should be on the market NOW.
Why is this stock price so low?
http://ih.advfn.com/videos/educational/nx-1207-a-novel-drug-designed-to-reduce-prostate-enlargement-and-improve-ur_NoRQw9b72WM
I have always said that. I know 4 men in my life as friends and family who have been affected by this and 1 that died from prostate cancer after a long battle. This could have made a difference in each one so they would not have needed surgery if caught early enough.
If this drug works and gets approved it would be a life changer for the male population around the world. BPH and/or prostate cancer affects most men after a certain age and the current treatments suc
I agree a partnership would help a lot.
Yes, that's why I think we need a partnership with BP. This would provide credence to the stock and drug. In turn institutional funds would move in and buy into what the company is "selling." This in turn would provide stability to the stock.
See how the horse must move before the cart?
Because of stupid day traders that move in on the huge runs. They always mess up everything because they buy and if they do not make money in a minute they sell the this low floater drops easy just like we run easy when we get buys on the ask. It is frustrating though.
Of course, with good news we should fly. The question however, is why can't the stock maintain its gains? It seems pop and drop is the MO.
Me too back over $4.00 then $5.00. I think we will get news to do it soon.
looks like low volume slight uptrend taking place. Would like to see NYMX get back over 4 and stay over for good.
I hold a pretty big long position here but will start buying heavy everytime it gets close to 3. It always runs back up. Right now I have to wait on the DRRX FDA decision about 9 days away and then I'll put that money here. all imo, glta longs.
Looks like NYMX found a bottom after all the massive groups loaded the other day. Day traders and flippers always mess up a great run by panic selling on red.
Refer to the insider buys chart even just going back 1 year. The NYMX insider buys are insane. That is likely what sparked todays huge run.
no news and out of the blue pop? don't tell me this will be another EVOK like 2 months ago. OFFERING!
* * $NYMX Video Chart 09-13-16 * *
Link to Video - click here to watch the technical chart video
They always protect themselves with options both down and up follow the volume!
Might be just an extraboost when needet ;) Lets See....
Shorts are always all over NYMX. They will get fried unexpectedly again. Look at the charts. The red and decline has been on tiny daily volume. IMO we will be back over $4.00 and $5.00 soon.
But i am more of a daytrader ,Looking at Volume Spikes... And specialy at Pharma companys... I am Doing more then well with my strategy... But Thats me.. I am 10years now in stockmarket And it took me a while to find my Way,But now it is close to be at it Perfektion for me ;)
But i am also Long in some Stocks wich i See Long for me... AAPL Since close to 10 Years,Facebook Since 40's....
If everyone just came here to day trade forget it. Do some real DD. Go into the charts on insider buys all year long. Go into the charts on the big news in late Aug. This is a good stock to own into much bigger news ahead IMO. The spike today was likely caused by automatic insider buying that lead to short covering.
For me it Looks like we See another Volume Spike and rise in pps soon
Just bought more on this dip.... Lest See ;)
Look at the news in late Aug. we ran to about $6.00. Insider buys have been insane all year. There must be more big news coming IMO. The entire float traded over $5.00 a share on the big news. It has been dropping on tiny volume since then.
Little Late to tha Party,But bought in 3,89...
Followers
|
42
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1137
|
Created
|
05/14/10
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |